Twenty-Year Collaboration Between North American and South American Retinoblastoma Programs.

Competing Interests: Authors' disclosures of potential conflicts of interest and contributions are found at the end of this article.The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/site/ifc. Guillermo L. ChantadaNo relationship to discloseIra J. DunkelConsulting or Advisory Role: Bristol-Myers Squibb, Ipsen, Esai Research Funding: Bristol-Myers Squibb (Inst), Genentech (Inst), GlaxoSmithKline (Inst)Paula S. SchaiquevichNo relationship to discloseEdith L. GrynszpancholcNo relationship to discloseJasmine FrancisNo relationship to discloseAlejandro CecilianoNo relationship to disclosePedro A. ZubizarretaNo relationship to discloseAdriana C. FañdinoNo relationship to discloseDavid H. AbramsonNo relationship to disclose